Rhaeos
Medical Devices, 170 Knowles Dr, Evanston, Illinois, 95032, United States, 11-50 Employees
Phone Number: 13*********
Who is RHAEOS
Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid ...
Read More
-
Headquarters: 170 Knowles Dr, Evanston, Illinois, 95032, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3829
|
NAICS Code: 334519 |
Show More
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Rhaeos
Answer: Rhaeos's headquarters are located at 170 Knowles Dr, Evanston, Illinois, 95032, United States
Answer: Rhaeos's phone number is 13*********
Answer: Rhaeos's official website is https://rhaeos.com
Answer: Rhaeos's revenue is $1 Million to $5 Million
Answer: Rhaeos's SIC: 3829
Answer: Rhaeos's NAICS: 334519
Answer: Rhaeos has 11-50 employees
Answer: Rhaeos is in Medical Devices
Answer: Rhaeos contact info: Phone number: 13********* Website: https://rhaeos.com
Answer: Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now with FlowSense. FlowSense, is a proprietary wireless, wearable, and noninvasive sensor that can be mounted on skin overlying the shunt to detect the presence and magnitude of CSF. Its miniaturized, thin construction is similar in size to a bandage, and it is composed primarily of soft, silicone rubber with no hard edges. Data is wirelessly transmitted to a custom designed mobile app. Rhaeos received FDA breakthrough designation for FlowSense, is NIH and NSF funded (>$7.5M), published clinical data in Science and Nature family journals, and is on track for initial market entry in 2024. To date, the company has brought in >$19M in dilutive and non-dilutive financing. Follow on products for other chronic conditions are currently in development.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month